Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07557901Enrolling by invitation
Randomised trial of fosfomycin in infectious complications (2 arms), sponsored by University Hospital F.D. Roosevelt. Primary endpoint: Incidence of post-biopsy infectious complications at 2 months. Started Apr 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07557901.